Response to the Comment on "The Impact of Prehabilitation on Patient Outcomes in Hepatobiliary, Colorectal, and Upper Gastro-intestinal Cancer Surgery: A PRISMA-Accordant Meta-analysis"

Affiliations

¹ School of Life and Health Sciences, University of the West of Scotland, Glasgow, G72 0LH, UK.
² Lancaster Medical School, Health Innovation One, Sir John Fisher Drive, Lancaster University, Lancaster, LA1 4AT, United Kingdom.
³ East Lancashire Hospitals Trust, Blackburn, United Kingdom.
⁴ Lancaster Medical School, Health Innovation One, Sir John Fisher Drive, Lancaster University, Lancaster, LA1 4AT, UK.

Comment

Joel Lambert et al. Ann Surg. 2021.

. 2021 Dec 1;274(6):e946-e947.

doi: 10.1097/SLA.0000000000005223.

¹ School of Life and Health Sciences, University of the West of Scotland, Glasgow, G72 0LH, UK.
² Lancaster Medical School, Health Innovation One, Sir John Fisher Drive, Lancaster University, Lancaster, LA1 4AT, United Kingdom.
³ East Lancashire Hospitals Trust, Blackburn, United Kingdom.
⁴ Lancaster Medical School, Health Innovation One, Sir John Fisher Drive, Lancaster University, Lancaster, LA1 4AT, UK.

No abstract available

Conflict of interest statement

The authors declare no conflict of interests.

The Impact of Prehabilitation on Patient Outcomes in Hepatobiliary, Colorectal, and Upper Gastrointestinal Cancer Surgery: A PRISMA-Accordant Meta-analysis.
Lambert JE, Hayes LD, Keegan TJ, Subar DA, Gaffney CJ. Lambert JE, et al. Ann Surg. 2021 Jul 1;274(1):70-77. doi: 10.1097/SLA.0000000000004527. Ann Surg. 2021. PMID: 33201129
Comment on: The Impact of Prehabilitation on Patient Outcomes in Hepatobiliary, Colorectal, and Upper Gastrointestinal Cancer Surgery: A PRISMA-Accordant Meta-analysis.
Fiore JF Jr, Gillis C, Touma N, Elhaj H. Fiore JF Jr, et al. Ann Surg. 2021 Dec 1;274(6):e945-e946. doi: 10.1097/SLA.0000000000005222. Ann Surg. 2021. PMID: 34596069 No abstract available.

1. Lambert JE, Hayes LD, Keegan TJ, et al. The impact of prehabilitation on patient outcomes in hepatobiliary, colorectal, and upper gastrointestinal cancer surgery: a PRISMA-accordant meta-analysis. Ann Surg 2021; 274:70–77.
1. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 2009; 339:b2700.
1. Shea BJ, Reeves BC, Wells G, et al. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ 2017; j4008.
1. Burda BU, Holmer HK, Norris SL. Limitations of a measurement tool to assess systematic reviews (AMSTAR) and suggestions for improvement. Syst Rev 2016; 5:58.
1. Armijo-Olivo S, da Costa BR, Cummings GG, et al. PEDro or cochrane to assess the quality of clinical trials? A meta-epidemiological study. PLoS One 2015; 10:e0132634.